Ronen Tchelet
Net Worth
Last updated:
What is Ronen Tchelet net worth?
The estimated net worth of Dr. Ronen Tchelet is at least $2,002,600 as of 8 Jul 2022. He owns shares worth $3,615 as insider, has earned $439,465 from insider trading and has received compensation worth at least $1,559,520 in Dyadic International, Inc..
What is the salary of Ronen Tchelet?
Dr. Ronen Tchelet salary is $259,920 per year as Vice President of Research & Bus. Devel. in Dyadic International, Inc..
How old is Ronen Tchelet?
Dr. Ronen Tchelet is 67 years old, born in 1958.
What stocks does Ronen Tchelet currently own?
As insider, Dr. Ronen Tchelet owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Dyadic International, Inc. (DYAI) | Vice President of Research & Bus. Devel. | 4,575 | $0.79 | $3,615 |
What does Dyadic International, Inc. do?
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U.; and collaboration with Syngene International Limited. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Ronen Tchelet insider trading
Dyadic International, Inc.
Dr. Ronen Tchelet has made 13 insider trades between 2019-2022, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 20,000 units of DYAI stock on 17 Jun 2019. As of 8 Jul 2022 he still owns at least 4,575 units of DYAI stock.
Dyadic International key executives
Dyadic International, Inc. executives and other stock owners filed with the SEC:
- Dr. Ronen Tchelet (67) Vice President of Research & Bus. Devel.
- Mr. Mark A. Emalfarb (69) Founder, Chief Executive Officer, Pres & Director
- Mr. Matthew S. Jones (47) Managing Director of Bus. Devel. & Licensing
- Ms. Ping Wang Rawson (49) Chief Financial Officer